Novartis AG is 181.9x more valuable than PRECIGEN, INC. by market capitalization ($293.70 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PGEN | NVS |
|---|---|---|
| Market cap | $1.61 B | $293.70 B |
| US-listed rank | #2268 | #46 |
| Revenue (latest FY) | $9.68M | - |
| Net income (latest FY) | -$250.60M | - |
| Net margin | -2587.8% | - |
| SEC filings | 1,273 | 947 |
Novartis AG is 181.9x more valuable than PRECIGEN, INC. by market capitalization ($293.70 B vs $1.61 B).
Full pages: PRECIGEN, INC. and Novartis AG, or browse the full rankings.